drug · small molecule
patient view →misoprostol
Phase 2updated 2mo agoby AFYX Therapeutics A/S🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 27 investigational indications.
targets
Prostaglandin E2 receptor EP3 subtype
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that